Advertisement
UK markets close in 8 hours
  • FTSE 100

    8,066.47
    +21.66 (+0.27%)
     
  • FTSE 250

    19,769.63
    -30.09 (-0.15%)
     
  • AIM

    755.51
    +0.64 (+0.08%)
     
  • GBP/EUR

    1.1627
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2433
    -0.0019 (-0.15%)
     
  • Bitcoin GBP

    53,770.23
    +398.41 (+0.75%)
     
  • CMC Crypto 200

    1,418.32
    -5.78 (-0.41%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.37
    +0.01 (+0.01%)
     
  • GOLD FUTURES

    2,336.20
    -5.90 (-0.25%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,180.18
    +351.25 (+2.09%)
     
  • DAX

    18,173.67
    +36.02 (+0.20%)
     
  • CAC 40

    8,085.74
    -20.04 (-0.25%)
     

Evonik Industries Third Quarter 2022 Earnings: Beats Expectations

Evonik Industries (ETR:EVK) Third Quarter 2022 Results

Key Financial Results

  • Revenue: €4.88b (up 26% from 3Q 2021).

  • Net income: €214.0m (down 7.4% from 3Q 2021).

  • Profit margin: 4.4% (down from 6.0% in 3Q 2021). The decrease in margin was driven by higher expenses.

  • EPS: €0.46 (down from €0.49 in 3Q 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Evonik Industries Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 11%. Earnings per share (EPS) also surpassed analyst estimates by 5.1%.

Looking ahead, revenue is forecast to grow 1.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat.

ADVERTISEMENT

Performance of the German Chemicals industry.

The company's shares are up 2.8% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Evonik Industries you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here